Sign In
Buy ENTX
$1.22
-0.0300 (-2.40%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:25pm, Thursday, 23'rd Jul 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) * ABIOMED, Inc. (NASDAQ: ABMD) * Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO) * Bio-Rad Laboratories, Inc. Class B Co
Entera Bio Ltd. Announces Highly Encouraging Oral PTH Market Survey Results
08:05pm, Wednesday, 22'nd Jul 2020
‒ Approximately 85% of Clinicians Surveyed Likely to Prescribe Oral Parathyroid Hormone (PTH) to Treat Moderate to Severe Osteoporosis ‒ ‒ Oral PTH Described by Clinicians as Potential Game-Cha
Entera Bio Ltd Provides Update on Phase 2 Clinical Trial of EB613 in Postmenopausal Women With Osteoporosis
12:30pm, Tuesday, 07'th Jul 2020
Entera Bio Ltd. (ENTX), a leader in the development of orally delivered large molecule therapeutics, announced receipt of approval from the IRBs at the clinical sites for the amendment to its Phase 2
Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results
10:30am, Thursday, 21'st May 2020
Entera Bio Ltd. (ENTX), a leader in the development of orally delivered large molecule therapeutics, announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteop
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
04:30pm, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online Thursday calling the shots. Earn
Entera Bio to Report Interim Data From EB613 Phase 2 Trial and First Quarter 2020 Business and Financial Results on May 21, 2020
12:30pm, Thursday, 07'th May 2020
Entera Bio Ltd. (ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report interim three-month top-line biomarker data for the first 50% of the patie
Head-To-Head Comparison: Seattle Genetics (NASDAQ:SGEN) vs. Entera Bio (NASDAQ:ENTX)
05:16am, Tuesday, 21'st Apr 2020
Seattle Genetics (NASDAQ:SGEN) and Entera Bio (NASDAQ:ENTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, divi
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) * Ra Pharmaceuticals Inc (NASDAQ: RARX)Down In The
ENTERA BIO LTD ANNOUNCES FINANCIAL AND OPERATING RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019
10:30am, Thursday, 26'th Mar 2020
Entera Bio Ltd. (ENTX), a leader in the development of orally delivered large molecule therapeutics, announced its financial and operational results for the quarter and year ended December 31, 2019.
Entera Bio Ltd. to Host Earnings Call
10:30am, Thursday, 26'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Entera Bio Ltd. (NASDAQ:ENTX) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 at 8:30 AM
ENTERA BIO TO REPORT 2019 BUSINESS AND FINANCIAL RESULTS ON MARCH 26, 2020
08:15pm, Monday, 16'th Mar 2020
Entera Bio Ltd. (ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report financial and business results for the quarter and year ended December 31,
Frost & Sullivan Releases Osteoporosis Drug Market Data
12:30pm, Tuesday, 04'th Feb 2020
Osteoporosis is defined as a systemic skeletal disorder characterized by low bone mass, deterioration of bone tissue leading to enhanced bone fragility, and a consequent increase in fracture risk. Thi
Entera Bio (NASDAQ:ENTX) vs. Orchard Therapeutics (NASDAQ:ORTX) Financial Review
06:30am, Thursday, 30'th Jan 2020
Entera Bio (NASDAQ:ENTX) and Orchard Therapeutics (NASDAQ:ORTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of the
Entera Bio Announces the Completion of $14.3 million Private Placement
09:30pm, Wednesday, 18'th Dec 2019
Entera Bio Ltd. (ENTX) (the “Company” or “Entera”), a global innovator in drug delivery platforms, announced today that it increased the size of and completed its previously announced private
Entera Announces Closing of Private Placement
10:00pm, Wednesday, 11'th Dec 2019
Entera Bio Ltd. (ENTX) (the “Company” or “Entera”), a global innovator in drug delivery platforms, announced today it has closed a private placement offering (the “Offering”) with a se
